Offer - Urjas Oil for just ₹ 1 X
Rebiyug DSR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
2 - 12 years (Child) |
|
Is the use of Rebiyug DSR safe for pregnant women?
Rebiyug DSR is safe to take during pregnancy.
Is the use of Rebiyug DSR safe during breastfeeding?
Rebiyug DSR can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Rebiyug DSR on the Kidneys?
Using Rebiyug DSR does not have any harmful effects on kidneys.
What is the effect of Rebiyug DSR on the Liver?
Rebiyug DSR may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rebiyug DSR on the Heart?
You can take Rebiyug DSR without any fear of damage to the heart.
Rebiyug DSR should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rebiyug DSR unless your doctor advises you to do so -
Is this Rebiyug DSR habit forming or addictive?
No, there is no any evidence that Rebiyug DSR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rebiyug DSR, you should not drive or work on any heavy machine, as Rebiyug DSR can make you drowsy.
Is it safe?
Yes, Rebiyug DSR is safe for use.
Is it able to treat mental disorders?
No, the use of Rebiyug DSR in mental disorders is not effective.
Interaction between Food and Rebiyug DSR
Taking Rebiyug DSR with food is safe.
Interaction between Alcohol and Rebiyug DSR
Consumption of alcohol and Rebiyug DSR together may have severe effects on your health.
Yes, Rebiyug DSR is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as a headache, itching, and rash. If you experience above-mentioned side effects after taking this medicine then do not hesitate to inform your doctor and follow his/her instructions.
Rebiyug DSR contains domperidone (dopamine D2-receptor antagonist). It works by inhibiting the neurotransmitter dopamine (a chemical messenger present in our body) from acting on the vomiting center present in the brain thus preventing nausea and vomiting which provides relief to the patient from nausea and vomiting.
No, Rebiyug DSR does not cause erectile dysfunction. It has not been reported by the patients who are taking it. It is not a known side effect of this drug.
Rebiyug DSR is a prescription drug, hence do not take it without consulting doctor. It can be harmful for patients to take this medicine without a doctor's advice.
No, Rebiyug DSR does not cause high blood sugar (hyperglycemia). It has not been reported by the patients who are taking it. You are advised to monitor your blood sugar level on daily basis. If you notice high blood sugar levels after taking this drug, then discuss it with your doctor who might change the dosage of your current medications.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 666-667
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1310-1311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078